R. Tadayoni

Discipline

Type

Articles (3) Reviews (1)

Co-author

EHC van Dijk

Y. Subhi

R.O. Schlingemann

G. Querques

A.J. Lotery

F.G. Holz

K.B. Freund

RMH Diederen

CMG Cheung

CJF Boon

D. Zur

M. Zhao

S. Yzer

L.A. Yannuzzi

C.C. Wykoff

S. Sivaprasad

M.J. Sirks

N. Rosenberg

S.G. Priglinger

LJB Pauleikhoff

M.C. Naud

A. Loewenstein

M. Larsen

CAK Lange

TYY Lai

H. Koizumi

C. Klein

P.K. Kaiser

L. Jonet

C.B. Hoyng

CEM Hollak

HMA Feenstra

C.M. Eandi

S.M. Downes

Y. De Kozak

A. Couturier

I. Chowers

J.K. Chhablani

M.P. Breazzano

E. Bousquet

S. Aslanis

Date

Source

Serveur académique Lausannois (3)

Keyword

Treatment (3) loss (2) information (2) effect (2) Diseases (2) Vision (2) Retina (2) Photochemotherapy (2) Patients (2) Human beings (2) Growth (2) Fluorescence angiography (2) Example (2) Evidence (2) Drugs (2) Diseases (2) Choroid (2) Verteporfin (2) Use (2) Patients (2) Growth (2) world (1) therapy (1) state (1) quality of life (1) protein (1) opinion (1) model (1) management (1) antibody (1)

Documents written by R. Tadayoni (3) | is about R. Tadayoni (0)

Central serous chorioretinopathy: An evidence-based treatment guideline.

HMA Feenstra et al.

Clinical impact of the worldwide shortage of verteporfin (Visudyne®) on ophthalmic care.

M.J. Sirks et al.

Anti-vascular endothelial growth factor acts on retinal microglia/macrophage activation in a rat model of ocular inflammation.

A. Couturier et al. (2014)